Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins-Reference-Cited by-同舟云学术

Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins

Published:2003-02 Issue:2 Volume:141 Page:131-137
ISSN:0022-2143
Container-title:Journal of Laboratory and Clinical Medicine
language:en
Short-container-title:Journal of Laboratory and Clinical Medicine

Author:

Miettinen Tatu A.,Gylling Helena,Lindbohm Nina,Miettinen Tatu E.,Rajaratnam Radhakrishnan A.,Relas Heikki

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference26 articles.

1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS;Downs;JAMA,1998

5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischaemic Disease LIPID Study Group;N Engl J Med,1998

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of plasma phytosterols in sitosterolemia, their kindreds and hyperlipidemia subjects;Journal of Clinical Lipidology;2024-09

2. Exquisite Balance Between Cholesterol Synthesis and Cholesterol Absorption in Human;Journal of Atherosclerosis and Thrombosis;2023-09-01

3. Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment;International Journal of Molecular Sciences;2022-03-22

4. Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial;Journal of Atherosclerosis and Thrombosis;2022

5. Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol;International Journal of Cardiology;2021-05